What Does Wall Street Think About Savara Inc. (SVRA)?

By Yahoo! Finance   |   1 month ago
What Does Wall Street Think About Savara Inc. (SVRA)?

Savara Inc. (NASDAQ:SVRA) has seen positive outlook with price target increase to $11. Analysts predict high demand for Molbreevi, indicating potential for blockbuster sales. The company focuses on rare respiratory diseases, offering promising investment opportunities.

Read More

Did you find this insightful?